Webcast ImageWebcast
Clovis Oncology, Inc.at 2016 Credit Suisse Healthcare Conference (Replay)
11/08/16 at 1:00 p.m. MT
Clovis Oncology, Inc.at 2016 Credit Suisse Healthcare Conference
Tuesday, November 8, 2016 1:00 p.m. MT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs target specific subsets of cancer, and we seek to simultaneously develop, with partners, companion diagnostics that direct our product candidates to the patients most likely to benefit from their use. We believe this approach to personalized medicMore >>

Stock Chart
Stock chart for: 03NA000000CLVS
Stock Quote
CLVS (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Up 0.47 (1.32%)
Intraday High$36.88
Intraday Low$35.35
Data as of 12/02/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
11/03/16Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update
Rucaparib New Drug Application (NDA) accepted for Priority Review in the treatment of advanced BRCA-mutant ovarian cancer; PDUFA date February 23, 2017 Rucaparib MAA submission submitted this week Clovis commercial and medical affairs organizations preparing for potential U.S. commercial launch of rucaparib ARIEL3 pivotal rucaparib maintenance study enrollment completed; data expected i... 
Printer Friendly VersionDownload PDF
10/31/16Clovis Oncology to Present at the 2016 Credit Suisse Healthcare Conference
BOULDER, Colo.--(BUSINESS WIRE)--Oct. 31, 2016-- Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick Mahaffy, the Company’s President and CEO, will present at the 2016 Credit Suisse Healthcare Conference on Tuesday, November 8, at 1:00pm MST. The conference is being held at the Phoenician in Scottsdale, Arizona. A live webcast of the corporate presentation at the conference will be accessible through the investor relations se... 
Printer Friendly VersionDownload PDF
10/27/16Clovis Oncology to Announce Third Quarter 2016 Financial Results and Host Webcast Conference Call on November 3
BOULDER, Colo.--(BUSINESS WIRE)--Oct. 27, 2016-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its third quarter 2016 financial results on Thursday, November 3, 2016, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company’s results in greater detail. The conference call is being webcast and can be accessed from the Clovis ... 
Printer Friendly VersionDownload PDF
Upcoming EventsMore >>
There are currently no events scheduled.
Receive Email AlertsEmail Alert Icon
Sign up to receive email alerts whenever Clovis Oncology, Inc. posts new information to the site. Just enter your email address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.